Optometrists in Cobleskill, NY Accepting Medicare
5 Optometrists found. Showing 1 - 5
 Mr. Bruce V Taggart, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 980 E Main St Ste 2, Cobleskill, NY 12043 Phone: 518-234-2020 Fax: 518-234-0092 |
 Village Eye Care Inc Optometrist Medicare: Medicare Enrolled Practice Location: 1698 State Route 7, Cobleskill, NY 12043 Phone: 518-234-2931 |
Looking Ahead Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 980 E Main St Ste 4, Cobleskill, NY 12043 Phone: 518-823-4145 |
Dr. Brian P Maillard, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1698 State Route 7, Cobleskill, NY 12043 Phone: 518-234-2931 Fax: 518-234-0140 |
 Dr. Tanya Devlin, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 139 Merchant Pl, Cobleskill, NY 12043 Phone: 518-234-1155 Fax: 518-254-0691 |
News Archive
FDA issues warning letters to companies for illegally selling hangover remedies
Today, the U.S. Food and Drug Administration announced it has issued warning letters to seven companies for illegally selling unapproved products labeled as dietary supplements that claim to cure, treat, mitigate or prevent hangovers, in violation of the Federal Food, Drug, and Cosmetic Act (FD&C Act).
Research looks at hepatitis C recovery
More than 3% of world population is infected with hepatitis C virus (HCV). The outcome of HCV infections is either self recovery or chronic hepatitis, and many of the chronic infections will develop into liver cirrhosis or liver cancer.
Canadian researchers launch world's first viral therapy clinical trial to attack and kill cancer cells
Canadian researchers have launched the world's first clinical trial of a novel investigational therapy that uses a combination of two viruses to attack and kill cancer cells, and stimulate an anti-cancer immune response. Previous research by this team and others worldwide suggests that this approach could be very powerful, and could have fewer side effects than conventional chemotherapy and radiation, although it will take years to rigorously test through this trial and others.
Scientists discover serum biochemical signature that predicts Alzheimer's
Scientists from VTT Technical Research Centre of Finland in collaboration with the University of Eastern Finland have recently discovered a serum biochemical signature which predicts progression to Alzheimer's disease months or even years before the first symptoms of the disease occur. The goal of the new collaboration between VTT and GE Healthcare is to validate this biomarker in a large patient cohort as well as to discover novel biomarker candidates.
Patient monitoring technology helps mental health trust to reduce falls and save time
Coventry and Warwickshire Partnership NHS Trust saw falls at night drop by a third on two wards that introduced the Oxehealth Digital Care Assistant technology, a clinical study has shown.
› Verified 6 days ago
Physical Therapists
Speech-Language Pathologists
Chiropractors
Optometrists
Occupational Therapists